UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 147

Sortiert nach

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)

Annals of oncology, 2015-06, Vol.26 (6), p.1123-1128

2015

Volltextzugriff (PDF)

Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d′Étude des Tumeurs Uro-Génitales) study

European journal of cancer (1990), 2024-03, Vol.199, p.113534-113534, Article 113534

2024

Volltextzugriff (PDF)

All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study

Nephrology, dialysis, transplantation, 2014-02, Vol.29 (2), p.325-332

2014

Volltextzugriff (PDF)

A PET-based nomogram for oropharyngeal cancers

European journal of cancer (1990), 2017-04, Vol.75, p.222-230

2017

Volltextzugriff (PDF)

Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial

Annals of oncology, 2018-10, Vol.29, p.viii306-viii306

2018

Volltextzugriff (PDF)

Updated results of GETUG-12, a phase III trial of docetaxel-based chemotherapy in high-risk localized prostate cancer, with a 12-year follow-up

Annals of oncology, 2018-10, Vol.29, p.viii271-viii271

2018

Volltextzugriff (PDF)

A Nomogram to predict parotid gland overdose in head and neck IMRT

Radiation oncology (London, England), 2016-06, Vol.11 (1), p.79-79, Article 79

2016

Volltextzugriff (PDF)

Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma

Annals of oncology, 2010-01, Vol.21 (1), p.186-187

2010

Volltextzugriff (PDF)

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

The New England journal of medicine, 2016-12, Vol.375 (23), p.2246-2254

2016

Volltextzugriff (PDF)

PO-164: PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic salivary gland carcinoma

Radiotherapy and oncology, 2015-02, Vol.114, p.76-77

2015

Volltextzugriff (PDF)

2601 Outcome of relapses after adjuvant carboplatin in clinical stage I seminoma

European journal of cancer (1990), 2015-09, Vol.51, p.S511-S512

2015

Volltextzugriff (PDF)

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

The New England journal of medicine, 2018-08, Vol.379 (5), p.417-427

2018

Volltextzugriff (PDF)

Metastatic clear-cell renal cell carcinoma: Computed tomography texture analysis as predictive biomarkers of survival in patients treated with Nivolumab: NivoMics 01-Study

European urology open science (Online), 2020-07, Vol.19, p.e1103-e1104

2020

Volltextzugriff (PDF)

Randomized phase III trial of dose-dense MVAC or GC as perioperative chemotherapy for muscle-invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathological responses

European urology open science (Online), 2020-07, Vol.19, p.e108-e109

2020

Volltextzugriff (PDF)

KEYNOTE-365 cohort B updated results: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza) pre-treated patients with metastatic castration-resistant prostate cancer (mCRPC)

European urology open science (Online), 2020-07, Vol.19, p.e871-e872

2020

Volltextzugriff (PDF)

KEYNOTE-365 cohort c updated results: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients with metastatic Castration-Resistant Prostate Cancer (mCRPC)

European urology open science (Online), 2020-07, Vol.19, p.e875-e876

2020

Volltextzugriff (PDF)

Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results

European urology open science (Online), 2020-07, Vol.19, p.e873-e874

2020

Volltextzugriff (PDF)

PO-0881: Anatomical markers of parotid overdosage during IMRT for locally advanced H&N guiding an adaptive RT strategy

Radiotherapy and oncology, 2014, Vol.111, p.S96-S96

2014

Volltextzugriff (PDF)

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

British journal of cancer, 2001-09, Vol.85 (5), p.649-655

2001

Volltextzugriff (PDF)

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

Critical reviews in oncology/hematology, 2010-10, Vol.76 (1), p.71-78

2010

Volltextzugriff (PDF)

7143 POSTER Prognosis of Patients With Metastatic Renal Cell Carcinoma (mRCC) With Primary Resistance to Sunitinib: Is There Any Active Treatment?

European journal of cancer (1990), 2011, Vol.47, p.S518-S518

2011

Volltextzugriff (PDF)

2362MO Erdafitinib (erda) vs chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (mUC) with select FGFR alterations (FGFRalt): Subgroups from the phase III THOR study

Annals of oncology, 2023-10, Vol.34, p.S1201-S1201

2023

Volltextzugriff (PDF)

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2591-2598

2019

Volltextzugriff (PDF)

652O Dose-dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for patients with muscle-invasive bladder cancer (MIBC): Results of the GETUG/AFU VESPER V05 phase III trial

Annals of oncology, 2021-09, Vol.32, p.S678-S678

2021

Volltextzugriff (PDF)

Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma

Journal of clinical oncology, 2017-01, Vol.35 (2), p.194-200

2017

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Japanisch
(10)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(50)
Humans
(34)
Male
(21)
Female
(20)
Aged
(18)
Middle Aged
(18)
Life Sciences
(17)
Oncology
(17)
Biological And Medical Sciences
(15)
Animals
(14)
Adult
(13)
Physical Sciences
(11)
Chemistry
(10)
Dogs
(10)
Medical Sciences
(9)
Technology
(9)
Carcinoma, Renal Cell - Drug Therapy
(8)
Chemotherapy
(8)
Exact Sciences And Technology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)

Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d′Étude des Tumeurs Uro-Génitales) study

All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study

A PET-based nomogram for oropharyngeal cancers

Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial

Updated results of GETUG-12, a phase III trial of docetaxel-based chemotherapy in high-risk localized prostate cancer, with a 12-year follow-up

A Nomogram to predict parotid gland overdose in head and neck IMRT

Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

PO-164: PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic salivary gland carcinoma

2601 Outcome of relapses after adjuvant carboplatin in clinical stage I seminoma

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

Metastatic clear-cell renal cell carcinoma: Computed tomography texture analysis as predictive biomarkers of survival in patients treated with Nivolumab: NivoMics 01-Study

Randomized phase III trial of dose-dense MVAC or GC as perioperative chemotherapy for muscle-invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathological responses

KEYNOTE-365 cohort B updated results: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza) pre-treated patients with metastatic castration-resistant prostate cancer (mCRPC)

KEYNOTE-365 cohort c updated results: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients with metastatic Castration-Resistant Prostate Cancer (mCRPC)

Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results

PO-0881: Anatomical markers of parotid overdosage during IMRT for locally advanced H&N guiding an adaptive RT strategy

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

7143 POSTER Prognosis of Patients With Metastatic Renal Cell Carcinoma (mRCC) With Primary Resistance to Sunitinib: Is There Any Active Treatment?

2362MO Erdafitinib (erda) vs chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (mUC) with select FGFR alterations (FGFRalt): Subgroups from the phase III THOR study

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

652O Dose-dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for patients with muscle-invasive bladder cancer (MIBC): Results of the GETUG/AFU VESPER V05 phase III trial

Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma

Aktive Filter

Suchergebnisse filtern